Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L
-
Published source details
Gudmundsdottir B.K. & Gudmundsdottir S. (1997) Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L. Journal of Fish Diseases, 20, 343-350.
Published source details Gudmundsdottir B.K. & Gudmundsdottir S. (1997) Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L. Journal of Fish Diseases, 20, 343-350.
Actions
This study is summarised as evidence for the following.
Action | Category | |
---|---|---|
Use vaccinations Action Link |
-
Use vaccinations
In 1997, a replicated, controlled study in Iceland (Gudmundsdottir and Gudmundsdottir, 1997) found that vaccinating salmon, Salmo salar, with IBOO improved survival rates of fingerlings when exposed to a disease-causing bacteria, Aeromonas salmonicida spp. achromogenes. After 16 days, the lowest level of mortality (51%) was observed in groups vaccinated with IBOO compared with the unvaccinated control groups (81% mortality). Infection with the bacteria leads to the development of furunculosis in salmon. Vaccines were made from A.salmonicida spp. achromogenes strain M108-91, furunculosis vaccine and an oil adjuvant. Salmon were exposed to A.salmonicida spp. achromogenes 70 days post vaccination.
Output references
|